Cargando…
Mechanism of Action and Clinical Attributes of Auryxia(®) (Ferric Citrate)
Chronic kidney disease (CKD) is a major cause of morbidity and premature mortality and represents a significant global public health issue. Underlying this burden are the many complications of CKD, including mineral and bone disorders, anemia, and accelerated cardiovascular disease. Hyperphosphatemi...
Autores principales: | Ganz, Tomas, Bino, Avi, Salusky, Isidro B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562046/ https://www.ncbi.nlm.nih.gov/pubmed/31134521 http://dx.doi.org/10.1007/s40265-019-01125-w |
Ejemplares similares
-
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
por: Hanudel, Mark R., et al.
Publicado: (2022) -
Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease
por: Hanudel, Mark R., et al.
Publicado: (2022) -
Antiviral effects of ferric ammonium citrate
por: Wang, Hongbin, et al.
Publicado: (2018) -
Physicochemical characterization of ferric pyrophosphate citrate
por: Gupta, Ajay, et al.
Publicado: (2018) -
Ferric pyrophosphate citrate: interactions with transferrin
por: Pratt, Raymond, et al.
Publicado: (2018)